Home/Hillhurst Biopharmaceuticals/Bonnie Mills, PhD

BM

Bonnie Mills, PhD

Vice President, Regulatory Affairs

Hillhurst Biopharmaceuticals

Therapeutic Areas

Sickle Cell Disease Parkinson's Disease Acute Pain Diabetic Retinopathy

Hillhurst Biopharmaceuticals Pipeline

Drug	Indication	Phase
HBI-002	Parkinson's Disease	Phase 2a
Undisclosed	Sickle Cell Disease	Preclinical or Phase 1

Leadership Team at Hillhurst Biopharmaceuticals

Andrew Gomperts

President and Chief Executive Officer

Chief Commercial Officer

Senior Chemistry, Manufacturing, and Controls Advisor

View full Hillhurst Biopharmaceuticals profile